SYMBOL:

    Up to 100 tickers separated by a space
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
HI-TECH PHARMACAL
(NQNM:HITK Last Sale: 43.09 )
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQNM: (HITK : $43.09)
$481 million Market Cap at September 12, 2013
Employs 210.
Drugs SubIndustry up .00% / Health Industry up .00% Today

369 Bayview Avenue Research Report Earnings Snapshot - Last 12/10/17
Amityville, NY 11701 Fact Sheet
Phone: (516) 789-8228 Financial Statements
Fax: (516) 789-8429 Peer Comparison
Annual Reports

David S. Seltzer, Chmn./Pres, CEO, William Peters, CFO
Agreed to be acquired by AKORN (NQNM:AKRX) for $640 million August 27, 2013. Holders receive $43.50 cash per share. Offers branded and generic products for the general healthcare industry. Specializes in difficult to manufacture liquid and semi-solid dosage forms and produces a range of sterile ophthalmic, otic and inhalation products.
Historical Charts    Technical Analysis
No Historical Data available for HITK

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common HITK $43.09 $ 0 $43.01 $43.1 158,952 $28.7 $44.334 11,161
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121
Common Stock $480,927

Split, Dividend and Symbol Change Information
Date Symbol Transaction Dividend Split New Symbol
11-JAN-06 HITK Split 3 for 2
17-JAN-03 HITK Split 3 for 2
01-NOV-93 HITK Split 3 for 2

A123
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex